Consumption of high ω-3 fatty acid diet suppressed prostate tumorigenesis in C3(1) Tag mice

Carcinogenesis

Volumn 33, Issue 1, 2012, Pages 140-148

  Akinsete, Juliana A ^a   Ion, Gabriela ^a   Witte, Theodore R ^a   Hardman, W Elaine ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CANOLA OIL; CORN OIL; ESTRADIOL; FISH OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER PREVENTION; CANCER RISK; CANCER TISSUE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ESTRADIOL BLOOD LEVEL; FAT INTAKE; FEMALE; GENE EXPRESSION; LIPID DIET; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROGENY; PROSTATE; PROSTATE CANCER; RISK REDUCTION; TESTOSTERONE BLOOD LEVEL; TISSUE LEVEL;

EID: 84855393665     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr238     Document Type: Article

References (33)

1. Jemal,A. et al. (2010) Cancer statistics. CA Cancer J. Clin., 60, 277-300.
2. Jemal,A. et al. (2011) Global cancer statistics. CA Cancer J. Clin., 61, 69-90.
3. Platz,E. et al. (2006) Prostate cancer. 3rd edn In Schottenfeld, D and Fraumeni, JF. Jr (eds) Cancer Epidemiology and Prevention. Oxford University Press, Oxford, UK, 1128-1150[59].
4. Astorg,P. (2004) Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control, 15, 367-386.
5. Pandalai,P.K. et al. (1996) The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Res., 16, 815-820.
6. Weaver,K.L. et al. (2009) Effect of dietary fatty acids on inflammatory gene expression in healthy humans. J. Biol. Chem., 284, 15400-15407.
7. Rose,D.P. et al. (1991) Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate, 18, 243-254.
8. Rose,D.P. et al. (1999) Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther., 83, 217-244.
9. Connolly,J.M. et al. (1997) Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nudemice. Nutr. Cancer, 29, 114-119.
10. Terry,P. et al. (2001) Fatty fish consumption and risk of prostate cancer. Lancet, 357, 1764-1766.
11. Tzonou,A. et al. (1999) Diet and cancer of the prostate: a case-control study in Greece. Int. J. Cancer, 80, 704-708.
12. Hedelin,M. et al. (2007) Association of frequent consumption of fatty fish with prostate cancer risk is +modified by COX-2 polymorphism. Int. J. Cancer, 120, 398-405.
13. Chavarro,J.E. et al. (2008) A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality. Am. J. Clin. Nutr., 88, 1295-1303.
14. Shibata,M.A. et al. (1996) Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations. Cancer Res., 56, 4894-4903.
15. American Institute of Nutrition. (1977) Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J. Nutr., 107, 1340-1348.
16. Ion,G. et al. (2010) Maternal consumption of canola oil suppressed mammary gland tumorigenesis in C3(1) TAg mice offspring. BMC Cancer, 10, 81.
17. Shappell,S.B. et al. (2004) Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the bar Harbor meeting of the mouse models of human cancer Consortium prostate pathology committee. Cancer Res., 64, 2270-2305.
18. Narayanan,B.A. et al. (2004) Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Clin. Cancer Res., 10, 7727-7737.
19. Lanier,A.P. et al. (1980) Cancer in Alaskan Indians, Eskimos, and Aleuts. J. Natl Cancer Inst., 65, 1157-1159.
20. Giovannucci,E. et al. (1993) A prospective study of dietary fat and risk of prostate cancer. J. Natl Cancer Inst., 85, 1571-1579.
21. Augustsson,K. et al. (2003) A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol. Biomarkers Prev., 12, 64-67.
22. Maroulakou,I.G. et al. (1994) Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl Acad. Sci. USA, 91, 11236-11240.
23. Suh,J. et al. (2004) NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon? J. Cell. Biochem., 91, 100-117.
24. Huang,S. et al. (2001) Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene, 20, 4188-4197.
25. Uotila,P. et al. (2001) Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer. Urol. Res., 29, 23-28.
26. Henderson,B.E. et al. (1988) The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br. J. Cancer, 57, 216-218.
27. Thomas,J.A. et al. (1994) Effects of estrogens on the prostate. J. Androl., 15, 97-99.
28. DeKlerk,D.P. et al. (1979) Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. J. Clin. Invest., 64, 842-849.
29. Ho,S.M. (2004) Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J. Cell. Biochem., 91, 491-503.
30. Kaufman,J.M. et al. (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev., 26, 833-876.
31. Vermeulen,A. et al. (2002) Estradiol in elderly men. Aging Male, 5, 98-102.
32. Moore,R.J. et al. (1979) Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol. J. Clin. Invest., 63, 351-357.
33. Trachtenberg,J. et al. (1980) Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia. J. Clin. Invest., 65, 1051-1059.